Fidelity Investments’s Burning Rock Biotech BNR Stock Holding History

Fidelity Investments’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,390	Closed	-$1.86M	–	4355
2021 Q3	$1.86M	Sell	10,390 -140	-1%	-$31.1K	﹤0.01%	2580
2021 Q2	$3.1M	Sell	10,530 -66,260	-86%	-$19.6M	﹤0.01%	2449
2021 Q1	$20.7M	Sell	76,790 -43,830	-36%	-$13.3M	﹤0.01%	1793
2020 Q4	$27.9M	Buy	120,620 +90,060	+295%	+$24.2M	﹤0.01%	1568
2020 Q3	$7.66M	Sell	30,560 -14,245	-32%	-$3.38M	﹤0.01%	1918
2020 Q2	$12.1M	Buy	+44,805	New	+$12.3M	﹤0.01%	1744

Other funds holding BNR

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments's BNR Position: Q4 2021 in Review

Fidelity Investments sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 10,390 shares — an estimated $1.86M sold.

Fidelity Investments first reported a position in BNR in Q2 2020 and held it in 6 quarters. The position peaked at $27.9M in Q4 2020. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

Fidelity Investments reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
Fidelity Investments sold 10,390 Burning Rock Biotech shares in Q4 2021, an estimated $1.86M.
Fidelity Investments first reported a position in Burning Rock Biotech in Q2 2020 and held it in 6 quarters.
Fidelity Investments's Burning Rock Biotech position peaked at $27.9M in Q4 2020.
62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on Fidelity Investments's 13F filing for Q4 2021, filed 14 Feb 2022.